Key result
Korotkoff sound acoustics in CVD patients show greater low-frequency spectral content versus healthy controls.
Why the study?
Korotkoff sound generation remains controversial, limiting its physiological interpretation and clinical application.
Do acoustic features of Korotkoff sounds differ between healthy controls and patients with various cardiovascular diseases?
Cross-Sectional (n=98)
Do acoustic features of Korotkoff sounds differ between healthy controls and patients with various cardiovascular diseases?
Acoustic features of Korotkoff sounds differ significantly between healthy individuals and those with various cardiovascular diseases, providing a potential non-invasive assessment tool.
Answers are grounded in this paper and cite their sources.
May facilitate noninvasive arterial stiffness detection via Korotkoff acoustics; leaves open clinical adoption pending prospective validation.
Korotkoff sound generation remains controversial, limiting its physiological interpretation and clinical application. In this cross-sectional observational study, we developed a biomechanical model that couples an arterial wall spring-mass-damper system with Womersley-based blood flow, in which wall motion alters cross-sectional area and flow-related forces excite vibration. Korotkoff sounds were also recorded in 98 participants, including controls and patients with elevated arterial stiffness, hypertension, heart failure, aortic stenosis, or aortic regurgitation. All five pathological groups showed significant differences from controls in selected acoustic features. Cardiac abnormalities were associated with greater low-frequency spectral content, whereas hypertension and elevated arterial stiffness showed distinct amplitude-related characteristics. After calibration, the model showed significant agreement with the clinical data at the level of selected spectral features. These findings provide feature-level mechanistic support linking disease-related cardiovascular alterations to Korotkoff sound variation. Schematic illustration of a Korotkoff sound-based cardiovascular assessment framework and signal acquisition system.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2026) conducted a cross-sectional in Cardiovascular diseases (n=98). Korotkoff sound analysis vs. Controls was evaluated on Differences in selected acoustic features. Korotkoff sound acoustic features differed significantly between controls and patients with cardiovascular diseases, with cardiac abnormalities showing greater low-frequency spectral content.
Synapse has enriched 10 related papers. Consider them for comparative context: